The Role of Cardiac Biomarkers in Pregnancy
- 306 Downloads
Cardiovascular disease (CVD) is the leading cause of pregnancy-associated mortality, with an increasingly complex pregnant population. While our understanding of CVD in pregnancy continues to evolve, there remains a need to develop widely accessible tools to follow pregnant women both with and without preexisting disease with respect to cardiovascular risk, particularly for those presenting with symptoms suggestive of cardiovascular pathology. Thus, research is emerging with respect to the potential role of novel and established cardiac biomarkers in diagnosing and following CVD in pregnancy. Here, we review the normal hemodynamics of pregnancy and the behavior of various biomarkers in both normal and complicated pregnancies.
KeywordsPregnancy Cardiac biomarkers Preeclampsia Peripartum cardiomyopathy
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflicts of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
References and Recommended Reading
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of great importance
- 1.• Knight M, Nair M, Tuffnell D, Kenyon S, Shakespeare J, Brocklehurst P, et al. Saving lives, improving mothers’ care. Surveillance of maternal deaths in the UK 2012–14 and lessons learned to inform maternity care from the UK and Ireland confidential enquiries into maternal deaths and morbidity 2009–14. 2016 [cited 2/21/2017]. [cited 2/21/2017]. Available from: https://www.npeu.ox.ac.uk/downloads/files/mbrrace-uk/reports/MBRRACE-UK%20Maternal%20Report%202016%20-%20website.pdf. This report summarizes the causes of maternal mortality including cardiovascular causes in the United Kingdom from 2009–2014.
- 8.Robson SC, Hunter S, Boys RJ, Dunlop W. Serial study of factors influencing changes in cardiac output during human pregnancy. Am J Phys. 1989;256(4 Pt 2):H1060–5.Google Scholar
- 21.Dogan R, Birdane A, Bilir A, Ekemen S, Tanriverdi B. Frequency of electrocardiographic changes indicating myocardial ischemia during elective cesarean delivery with regional and general anesthesia: detection based on continuous Holter monitoring and serum markers of ischemia. J Clin Anesth. 2008;20(5):347–51.CrossRefPubMedGoogle Scholar
- 23.Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstetrics and gynecology. 2013;122(5):1122–31.Google Scholar
- 25.Ananth CV, Keyes KM, Wapner RJ. Pre-eclampsia rates in the United States, 1980–2010: age-period-cohort analysis. BMJ (Clinical research ed). 2013;347:f6564.Google Scholar
- 29.Alvarez-Fernandez I, Prieto B, Rodriguez V, Ruano Y, Escudero AI, Alvarez FV. N-terminal pro B-type natriuretic peptide and angiogenic biomarkers in the prognosis of adverse outcomes in women with suspected preeclampsia. Clinica chimica acta; international journal of clinical chemistry. 2016;463:150–7.CrossRefPubMedGoogle Scholar
- 31.Junus K, Wikstrom AK, Larsson A, Olovsson M. Early second-trimester plasma levels of NT-proBNP in women who subsequently develop early-onset preeclampsia. The Journal of Maternal-Fetal & Neonatal Medicine: the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstet. 2016:1–3.Google Scholar
- 35.Atis A, Aydin Y, Basol E, Goker N. Troponin I and homocysteine levels in mild and severe preeclampsia. Clinical and experimental obstetrics & gynecology. 2010;37(1):21–3.Google Scholar
- 37.Pergialiotis V, Prodromidou A, Frountzas M, Perrea DN, Papantoniou N. Maternal cardiac troponin levels in pre-eclampsia: a systematic review. The Journal of Maternal-Fetal & Neonatal Medicine: the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstet. 2016;29(20):3386–90.Google Scholar
- 48.• Zeisler H, Llurba E, Chantraine F, Vatish M, Staff AC, Sennstrom M, et al. Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia. N Engl J Med. 2016;374(1):13–22. A prospective multicenter observational study establishing that a sFlt-1 to PlGF ratio of 38 or lower for women with suspected pre-eclampsia has a high negative predictive value for excluding disease in the short term.CrossRefPubMedGoogle Scholar
- 58.Ismail S, Wong C, Rajan P, Vidovich MI. ST-elevation acute myocardial infarction in pregnancy: 2016 update. Clinical Cardiology. 2017.Google Scholar
- 62.•• Canobbio MM, Warnes CA, Aboulhosn J, Connolly HM, Khanna A, Koos BJ, et al. Management of pregnancy in patients with complex congenital heart disease: a scientific statement for healthcare professionals from the American Heart Association. Circulation. 2017;135(8):e50–87. Recently published guidelines by the American Heart Association on the management of pregnancy in women with complex congenital heart disease.CrossRefPubMedGoogle Scholar